News
-
-
-
-
-
-
-
PRESS RELEASE
Volta Medical conclut un accord de développement conjoint avec GE HealthCare afin d’améliorer les procédures d’arythmies grâce à des technologies d’électrophysiologie basées sur l’IA
Volta Medical et GE HealthCare concluent un accord pour améliorer les procédures d'arythmies avec des technologies d'électrophysiologie basées sur l'IA -
PRESS RELEASE
Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies
Volta Medical partners with GE HealthCare to enhance arrhythmia procedures using AI-driven electrophysiology technologies. Collaboration focuses on improving patient outcomes for atrial fibrillation -
-
PRESS RELEASE
Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer
Jaguar Health, Inc. announces initial results from Phase 3 OnTarget trial of crofelemer for cancer patients' diarrhea prophylaxis. Positive signals for breast and respiratory cancer subgroups in multicenter, double-blind study